Article
Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy
2022-10-14
Abstract excerpt
Chronic myeloid leukemia (CML) is a blood cancer characterized by dysregulated production of maturing myeloid cells driven by the product of the Philadelphia chromosome, the BCR-ABL1 tyrosine kinase. Tyrosine kinase inhibitors (TKI) have proved effective in treating CML but there is still a cohort of patients who do not respond to TKI therapy even in the absence of mutations in the BCR-ABL1 kinase domain that medi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 347bc8d7-1018-5b84-952c-d114631d8295
- DOI
- 10.1101/2022.10.11.511822
